Exchange: OTC·Updated 03:59 PM EDT
Upcoming Earnings: Q2 '26

Reports: Aug 12After Hours

Estimated EPS

-$0.50

Estimated Rev

$6.35M

$BSEM Q1 '26 Earnings Results & Recap BioStem Technologies expects full year 2026 revenue to range from $25M to $29M, with sequential growth in both hospital and physician office businesses anticipated in the second half of 2026.

Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q2 '26
-$0.50
--
--
N/A
Q1 '26
-$0.28
-$0.52
-85.71%
MISSED
Q4 '25
$0.02
-$0.67
-3450.00%
MISSED
Q3 '25
$0.00
$0.03
100.00%
BEAT
Q2 '25
$0.32
-$0.03
-109.38%
MISSED

Advertisement|Remove ads.